BF Biosciences (BFBIO)
Pakistan Stock Exchange (PSX) · Pakistan · prices in PKR · close of 28 Oct 2026
Key indicators
| Last close | PKR 122.16 |
|---|---|
| 52-week range | 117.20 – 177.99 |
| Return, 1 month / 3 months | −4.2% / −5.6% |
| Return, 1 year / 3 years | −20.5% / – |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 35.5% |
| Worst drawdown (1 year) | -30.3% |
| Average daily value traded | 25.18M PKR |
| Dividend yield | – |
Market X-Ray price-based
Fair value limited data
Five-year price chart navy: price · brown: 200-day average · blue band: fair value range
About the company
BF Biosciences Limited is a pharmaceutical company whose core operations involve the import, manufacturing, marketing and distribution of pharmaceutical products. It operates within the pharmaceutical industry as a joint venture between Ferozsons Laboratories Limited and the Bagó Group of Argentina. Pharmaceutical products are medicines and related preparations made for treating and preventing illness, and bringing them to market typically spans importing, manufacturing, promotion and distribution to those who prescribe and use them.
The shares are listed on the Pakistan Stock Exchange (PSX) under the code BFBIO, and the price on this page is in Pakistani rupees (PKR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
BF Biosciences (BFBIO) trades on the Pakistan Stock Exchange (PSX) in Pakistan. It last closed at PKR 122.16 on 28 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 230 of 542 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.5% and over the last three months it fell 5.6%. Returns are price returns, dividends not included.
Our limited-data fair value is PKR 148.75 (Undervalued, +20.7% to fair value). It averages 3 models built from the earnings and sales this exchange publishes. Their weights were fitted to a professional consensus-style valuation of Pakistani stocks and checked on stocks left out of the fit, but no analyst forecasts are used, so read it as a rough range.
The five lenses in numbers each metric is ranked against the other stocks on Pakistan Stock Exchange (PSX)
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 37 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.6% | ||
| From 52-week high | -28.5% | ||
| Momentum | 39 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.1% | ||
| 6-month return | -15.8% | ||
| 12-month return, skipping the last month | -17.4% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.3% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 25.18M PKR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −3.4% |
|---|---|
| 1 month | −4.2% |
| 3 months | −5.6% |
| 6 months | −13.7% |
| 1 year | −20.5% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 127.14 / 139.29 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.84 |
Technical summary
Fair value models PSX income statement only (no balance sheet or cash flow): only earnings, sales and dividend models can be built
| P/E multiple | PKR 151.85 |
|---|---|
| P/S multiple | PKR 151.88 |
| P/E on average earnings | PKR 142.50 |
How to read this report
Every number comes from end-of-day prices and dividends and the earnings and sales this exchange publishes. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Pakistan Stock Exchange (PSX); it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.